Trade PPCB anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Propanc Biopharma, Inc. (PPCB) is trading at US$1.76, down 20.90% today as of Aug 28, 10:21 EDT. The company has a market capitalisation of US$2.46M. Over the past 52 weeks, PPCB has traded between US$0.95 and US$81.00. On Syfe you can trade PPCB with $0 commission and add it to your watchlist.
| Previous close | US$2.23 |
|---|---|
| Market cap | US$2.46M |
| 52-week range | US$0.95 – US$81.00 |
| Volume | 95.88M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Propanc Biopharma, Inc.
Propanc Biopharma, Inc. is a development-stage healthcare company, which engages in the research and development of cancer treatments. The firm focuses on the treatment of pancreatic, ovarian, and colorectal cancer. It offers its product pipeline, including PRP and POP1. The company was founded by James Nathanielsz and Julian Kenyon on October 15, 2007 and is headquartered in Camberwell, Australia.
Year: 2012
Propanc Biopharma Signs MoU With Avance Clinical to Jointly Undertake Advanced Solid Tumors Study
Jul 7, 1:09 PM · MT Newswires
Propanc Biopharma Launches $5 Million Stock Buyback Plan; Shares Rise
Jul 2, 1:18 PM · MT Newswires
Top Midday Gainers
Jun 11, 5:37 PM · MT Newswires
Propanc Biopharma Authorizes $5 Million Stock Buyback Program; Shares Jump
Jun 11, 2:07 PM · MT Newswires
Top Premarket Gainers
Jun 11, 11:00 AM · MT Newswires
Propanc Biopharma, Inc. (PPCB) stock is trading at US$1.76, -20.90% from the previous close of US$2.23.
The market cap for Propanc Biopharma, Inc. (PPCB) stock is approximately US$2.46M.
The 52-week high for Propanc Biopharma, Inc. (PPCB) stock is US$81.00.
The 52-week low for Propanc Biopharma, Inc. (PPCB) stock is US$0.95.
Propanc Biopharma, Inc. (PPCB) does not currently pay a dividend.
Stay on top of PPCB
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
